Login
Please select your location and reference genome:
Enabling Genomic Medicine 2021
epilepsy
genomics
RareDiseases
EVENT
precision medicine
EGM2021

Enabling Genomic Medicine 2021

10/15/2021    |    0 min read

Enabling Genomic Medicine 2021:  Best practice in genomic analysis

Our virtual event on 13 October 2021 featured some of the world's leading experts in precision medicine who came together to discuss the latest innovations and best practices in genomics to enable routine clinical care, diagnosis, and treatment. 

 

Catch up on all the sessions from Enabling Genomic Medicine (EGM) 2021 by viewing the recorded presentations below.


Richard Durbin, PhD, Informatics Director, Congenica and Professor of Genetics, University of Cambridge: 

Long-read sequencing and new reference genomes

 


Chris Wigley, CEO, Genomics England:

To Infinity and Beyond – working together to bring genomic medicine to EVERYONE

 

 


Parul Jayakar, MD, MS, FACMG, Director Division of Genetics and Metabolism, Nicklaus Children's Hospital Miami, Florida: 

From bench to bedside: Best practices in diagnosing and treating pediatric patients with epilepsy

 


Professor Norman Delanty, FRCPI, Consultant Neurologist, Beaumont Hospital, School of Pharmacy and Biomolecular Sciences, FutureNeuro Research Centre, Royal College of Surgeons in Ireland, Dublin: 

Precision therapies in the epilepsies

 


Dr. Luis Izquierdo, Chief Medical Officer, Doctor of Medicine and Surgery, Veritas Intercontinental and Miriam Leon, Head of Clinical Analysis and Curation, Veritas Intercontinental:

Prenatal diagnosis using Whole Exome Sequencing (WES)

 


Alistair Johnson, Chief Product Officer, Congenica:

Latest Developments in Next-Generation Genomic Analysis

 

Thank you to our speakers and all those who attended, we look forward to seeing you in 2022.

 

In the meantime, stay up to date with all Congenica news, including notice of future events and webinars, by signing up to our newsletter.

  

Sign up for Congenica news